Safety and Efficacy of Sofosbuvir with Ribavirin® in Hepatitis C, Genotype 3 Patients with Cirrhosis: A Real-world Experience

Introduction Hepatitis C virus (HCV) is the leading cause of cirrhosis. The advent of Directly Acting Antivirals (DAAs) like Sofosbuvir (SOF) has dramatized the treatment and is the cornerstone for the treatment of HCV. Most trials have been conducted in HCV genotype 1 (GT-1) and data for Interferon...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Nazish, Akbar, Ali, Abbasi, Amanullah, Reema, Sehrish, Baqar, Jaffer Bin, Shaikh, Qurban Hussain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450597/
https://www.ncbi.nlm.nih.gov/pubmed/31001466
http://dx.doi.org/10.7759/cureus.4012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450597/
https://www.ncbi.nlm.nih.gov/pubmed/31001466
http://dx.doi.org/10.7759/cureus.4012

Ejemplares similares